Racial disparity in survival from estrogen and progesterone receptor-positive breast cancer: implications for reducing breast cancer mortality disparities-Reference-Cited by-同舟云学术

Racial disparity in survival from estrogen and progesterone receptor-positive breast cancer: implications for reducing breast cancer mortality disparities

Published:2017-03-01 Issue:2 Volume:163 Page:321-330
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Rauscher Garth H.^ORCID,Silva Abigail,Pauls Heather,Frasor Jonna,Bonini Marcelo G.,Hoskins Kent

Funder

National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-017-4166-z.pdf

Reference53 articles.

1. Ansell D, Whitman S, Lipton R, Cooper R (1993) Race, income, and survival from breast cancer at two public hospitals. Cancer 72:2974–2978

2. Baquet CR, Mishra SI, Commiskey P, Ellison GL, DeShields M (2008) Breast cancer epidemiology in blacks and whites: disparities in incidence, mortality, survival rates and histology. J Natl Med Assoc 100:480–488

3. Curtis E, Quale C, Haggstrom D, Smith-Bindman R (2008) Racial and ethnic differences in breast cancer survival: how much is explained by screening, tumor severity, biology, treatment, comorbidities, and demographics? Cancer 112:171–180

4. Whitman S, Orsi J, Hurlbert M (2012) The racial disparity in breast cancer mortality in the 25 largest cities in the United States. Cancer Epidemiol 36:e147–e151

5. Whitman S, Ansell D, Orsi J, Francois T (2011) The racial disparity in breast cancer mortality. J Commun Health 36:588–596

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A qualitative study of Black breast cancer previvors' and survivors' experiences after positive genetic testing;Journal of Genetic Counseling;2024-06-06

2. Epidemiology of early vs late recurrence among women with early stage estrogen receptor–positive breast cancer in the Pathways Study;JNCI: Journal of the National Cancer Institute;2024-06-06

3. Racial disparities in outcomes of patients with stage I-III triple-negative breast cancer after adjuvant chemotherapy: a post-hoc analysis of the E5103 randomized trial;Breast Cancer Research and Treatment;2024-04-23

4. BIRC5 expression by race, age and clinical factors in breast cancer patients;Breast Cancer Research;2024-03-21

5. Differential response to neoadjuvant endocrine therapy for Black/African American and White women in NCDB;Breast Cancer Research and Treatment;2023-09-23